Ting Gong

Aug 16, 2024 | dovepress.com | Kun Qin |Ting Gong |Shi-Fan Ruan |Min Lin

Back to Journals » Journal of Inflammation Research » Volume 17 Authors Qin K , Gong T, Ruan SF, Lin M, Su X, Lv X, Cheng B, Ji C Received 16 August 2024 Accepted for publication 17 October 2024 Published 22 October 2024 Volume 2024:17 Pages 7591—7605 DOI https://doi.org/10.2147/JIR.S491791 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Ning Quan Kun Qin,1,2,* Ting Gong,3,* Shi-Fan Ruan,1,* Min...

Dec 13, 2023 | dovepress.com | Min Lin |Ting Gong |Xiaoqing Lv |Shifan Ruan

IntroductionAnticancer drugs, including anticancer chemotherapy, targeted therapy, and immune checkpoint inhibitors (ICIs), represent potent therapeutic options for various cancers. Their approval marked a significant milestone in the history of cancer therapy, sparking a transformative paradigm shift. However, the use of these drugs has been associated with numerous reported cases of adverse reactions.

Aug 14, 2023 | mdpi.com | Ting Gong |Qi Zhu

1. IntroductionWith the rapid development of vehicular networks, more and more in-vehicle applications are enriching the functions of vehicles, such as intelligent transportation, in-vehicle entertainment, in-vehicle office, road safety, and driverless applications. Vehicles need to obtain a variety of information from the outside world, such as traffic information, entertainment information, and real-time news, in order to provide users with a better driving experience.